These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19046115)

  • 1. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
    Ku GY; Ilson DH
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative therapy for esophageal cancer.
    Ku GY; Ilson DH
    Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
    Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Zuccaro G; Vargo JJ; Dumot JA; Carroll MA
    Am J Clin Oncol; 2007 Apr; 30(2):172-80. PubMed ID: 17414467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach.
    Lerut T; Moons J; Coosemans W; Decaluwé H; Decker G; De Leyn P; Nafteux P; Van Raemdonck D
    Surg Oncol Clin N Am; 2008 Jul; 17(3):485-502, vii-viii. PubMed ID: 18486879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
    Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized adenocarcinoma of the esophagogastric junction--is there a standard of care?
    Power DG; Reynolds JV
    Cancer Treat Rev; 2010 Aug; 36(5):400-9. PubMed ID: 20117883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality therapy of local regional esophageal cancer.
    Kelsen DP
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization.
    Kleinberg L; Gibson MK; Forastiere AA
    Nat Clin Pract Oncol; 2007 May; 4(5):282-94. PubMed ID: 17464336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
    Hingorani M; Crosby T; Maraveyas A; Dixit S; Bateman A; Roy R
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):696-705. PubMed ID: 21684129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the proximal esophagus: report of 9 patients and review of the literature.
    Marano S; Ruol A; Castoro C; Portale G; Cagol M; Alfieri R; Michieletto S; Ancona E
    Ann Surg Oncol; 2008 Oct; 15(10):2910-4. PubMed ID: 18696159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
    J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant therapy of esophageal carcinoma.
    Reed CE
    Chest Surg Clin N Am; 1994 May; 4(2):299-314. PubMed ID: 8049998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy in the multimodal management of esophageal cancer.
    Fokas E; Weiss C; Rödel C
    Dig Dis; 2013; 31(1):30-7. PubMed ID: 23797120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy for esophageal cancer: current status and perspectives.
    Ohtsu A
    Int J Clin Oncol; 2004 Dec; 9(6):444-50. PubMed ID: 15616874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.